Back

Effectiveness of Tocilizumab, Sarilumab, and Anakinra for critically ill patients with COVID-19 The REMAP-CAP COVID-19 Immune Modulation Therapy Domain Randomized Clinical Trial

2021-06-22 intensive care and critical care medicine Title + abstract only
View on medRxiv
Show abstract

BACKGROUNDThe interleukin-6 receptor antagonist tocilizumab improves outcomes in critically ill patients with coronavirus disease 2019 (COVID-19). However, the effectiveness of other immune modulating agents is unclear. METHODSWe evaluated four immunomodulatory agents in an ongoing international, multifactorial, adaptive platform trial. Adult participants with COVID-19 were randomized to receive tocilizumab, sarilumab, anakinra, or standard care (control). In addition, a small group (n=21) of p...

Predicted journal destinations

1
PLOS ONE
1737 training papers
Top 56% 11.1%
2
JAMA Network Open
125 training papers
Top 0.6% 7.4%
3
New England Journal of Medicine
49 training papers
Top 0.3% 6.1%
4
BMJ
49 training papers
#1 5.6%
5
Frontiers in Medicine
99 training papers
Top 1% 5.6%
6
BMJ Open
553 training papers
Top 31% 5.6%
7
Scientific Reports
701 training papers
Top 66% 3.9%
8
The Journal of Infectious Diseases
137 training papers
Top 4% 3.6%
9
Nature Communications
483 training papers
Top 30% 3.6%
10
Clinical Infectious Diseases
219 training papers
Top 11% 3.6%
11
Thorax
29 training papers
Top 1% 3.6%
12
Critical Care Explorations
15 training papers
Top 0.8% 3.6%
13
The Lancet Respiratory Medicine
16 training papers
#1 1.8%
14
BMC Medicine
155 training papers
Top 14% 1.8%
15
Frontiers in Immunology
140 training papers
Top 7% 1.8%
16
eLife
262 training papers
Top 31% 1.5%
17
European Respiratory Journal
44 training papers
Top 2% 1.5%
18
Clinical Microbiology and Infection
54 training papers
Top 3% 1.4%
19
PLOS Medicine
95 training papers
Top 12% 1.3%
20
The Lancet
16 training papers
#1 1.3%
21
Trials
24 training papers
Top 2% 1.1%
22
Journal of Medical Virology
95 training papers
Top 11% 0.9%
23
Clinical Pharmacology & Therapeutics
19 training papers
Top 1% 0.9%
24
Infectious Diseases and Therapy
18 training papers
Top 0.5% 0.9%
25
Vaccine
140 training papers
Top 9% 0.9%
26
Journal of Clinical Medicine
77 training papers
Top 24% 0.7%
27
Open Forum Infectious Diseases
124 training papers
Top 17% 0.7%
28
iScience
74 training papers
Top 15% 0.7%
29
Nature Medicine
88 training papers
Top 22% 0.7%